---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-030348"
form_type: "8-K"
ticker: "GYRE"
cik: "0001124105"
company_name: "GYRE THERAPEUTICS, INC."
filed_at: "2024-06-17T23:59:59+00:00"
generated_at: "2026-06-01T04:02:51.518972+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Gyre Therapeutics shareholders approve officer exculpation amendment, elect directors

## Summary
- All three Class III nominees elected: Thomas Eastling (68.9M for), Renate Parry (69.1M), Rodney Nussbaum (69.1M).
- Advisory vote on executive compensation approved with 69.1M for, 7,487 against.
- Ratification of Grant Thornton as auditor for FY 2024 passed (69.4M for, 7,601 against).
- Amendment to certificate of incorporation extending exculpation to certain officers approved (69.0M for).
- Certificate of amendment filed with Delaware on June 14, 2024, effective immediately.

## SEC filing metadata
- accession: 0001140361-24-030348
- form_type: 8-K
- ticker: GYRE
- cik: 0001124105
- company_name: GYRE THERAPEUTICS, INC.
- filed_at: 2024-06-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1124105/000114036124030348/0001140361-24-030348-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1124105/000114036124030348/ef20031213_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-030348
- JSON: https://secwatch.observer/filing/0001140361-24-030348.json
- Plain text: https://secwatch.observer/filing/0001140361-24-030348.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.